Budgetary Implications Of Introducing The Gsk Ellipta Portfolio For Copd In The Uk
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1395
https://www.valueinhealthjournal.com/article/S1098-3015(15)03471-3/fulltext
Title :
Budgetary Implications Of Introducing The Gsk Ellipta Portfolio For Copd In The Uk
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03471-3&doi=10.1016/j.jval.2015.09.1395
First page :
A497
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
892